Advertisement
Noticias de Forex
TSX Ends Marginally Down
The Canadian market ended marginally down on Monday, despite recovering from early lows. Consumer discretionary, healthcare, energy and materials shares were the major losers.
RTTNews |
hace 609
Swiss Market Ends On Firm Note
After opening weak and moving along the unchanged line till about mid afternoon, the Switzerland market began edging up on Monday to eventually end the day's session notably higher.
RTTNews
|
hace 609
Major European Markets Close Higher On Late Buying
Despite struggling for direction during much of the trading session, the major European markets closed higher on Monday as stocks found support past mid afternoon amid optimism the central banks will soon start reducing interest rates.
RTTNews
|
hace 609
Canadian Market Remains Weak Despite Coming Off Early Lows
After a weak start and a subsequent fall to lower levels, the Canadian market recovered some lost ground Monday morning with select stocks finding modest support.
RTTNews
|
hace 609
Dollar Rebounds In The Past Week As Rate Cut Hopes Soften
The week ended December 8 saw the Dollar staging a comeback after 3 weeks of declines. Waning optimism about a dovish Federal Reserve supported the Dollar's rebound.
RTTNews
|
hace 609
Popular Promotes Jorge Garcia To Succeed Carlos Vazquez As CFO
Popular, Inc. (BPOP) announced Monday that Carlos Vazquez will retire effective March 31, 2024 after serving as Chief Financial Officer since 2013, and in other senior leadership positions since joining Popular in 1997. He will be succeeded by Jorge Garcia, currently Corporate Comptroller and Chief Accounting Officer.
RTTNews
|
hace 609
Ascendis Pharma Says FDA Accepts Resubmitted NDA For TransCon PTH In Adults With Hypoparathyroidism
Ascendis Pharma A/S (ASND) announced Monday that the U.S. Food & Drug Administration (FDA) has accepted for review the Company's resubmitted New Drug Application (NDA) for TransCon PTH (palopegteriparatide) for the treatment of adult patients with hypoparathyroidism.
RTTNews
|
hace 609
more news
Jeffs' Brands Ink Deal To Distribute Bolly Jon's Biotech-Beauty Hair Products On Amazon
e-commerce company Jeffs' Brands Ltd. (JFBR, JFBRW) announced Monday its latest market expansion through an exclusive distribution agreement with Bolly Jon Ltd., a biotech-beauty hair care product brand.
RTTNews
|
hace 609
Swiss Franc Falls Against Most Majors
The Swiss franc depreciated against its most major counterparts in the European session on Monday.
RTTNews
|
hace 609
BlackBerry Promotes John Giamatteo To CEO; To Pursue Separation Of IoT And Cybersecurity Business
Intelligent security software firm BlackBerry Ltd. (BB, BB,TO) announced Monday the appointment of John Giamatteo as its new Chief Executive Officer and as a member of its Board of Directors, effective immediately. Giamatteo has served as the President of BlackBerry's Cybersecurity business unit since October 2021.
RTTNews
|
hace 609
Pembina Pipeline Sets C$880 Mln Capital Investment Program For 2024
While providing financial guidance for the full-year 2024 on Monday, Pembina Pipeline Corp. (PBA, PPL.TO) expects adjusted EBITDA of C$3.725 billion to C$4.025 billion.
RTTNews
|
hace 609
Bay Street Likely Seen Opening On Subdued Note
Canadian shares look headed for a muted start Monday morning, amid a lack of positive triggers. With several central banks, including the Federal Reserve, scheduled to announce their monetary policy decisions this week, the mood is likely to remain cautious.
RTTNews
|
hace 609
Orchard Therapeutics Gets Swissmedic Approval For Libmeldy In Early-onset MLD
Gene therapy leader Orchard Therapeutics plc (ORTX) announced Monday the Swiss Agency for Therapeutic Products (Swissmedic) has approved Libmeldy (atidarsagene autotemcel), a hematopoietic stem cell (HSC) gene therapy, for the treatment of early-onset metachromatic leukodystrophy (MLD).
RTTNews
|
hace 609
Stay up to date!
Add Noticias to your browser
Add To Chrome
